Suppr超能文献

人类耳蜗耳硬化症的动态分子标志物。

Dynamic Molecular Markers of Otosclerosis in the Human Cochlea.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Augusta University/Medical College of Georgia, Augusta, GA, USA.

Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

Ann Otol Rhinol Laryngol. 2024 Apr;133(4):390-399. doi: 10.1177/00034894231225134. Epub 2024 Jan 10.

Abstract

OBJECTIVE

To investigate the role and distribution of various molecular markers using immunohistochemistry and immunofluorescence to further elucidate and understand the pathogenesis of otosclerosis.

METHODS

Archival celloidin formalin-fixed 20-micron thick histologic sections from 7 patients diagnosed with otosclerosis were studied and compared to controls. Sections in the mid-modiolar region were immunoreacted with rabbit polyclonal antibodies against nidogen-1, β2-laminin, collagen-IX, BSP, and monoclonal antibodies against TGF β-1 and ubiquitin. Digital images were acquired using a high-resolution light and laser confocal microscope.

RESULTS

Nidogen-1, BSP, and collagen-IX were expressed in the otospongiotic regions, and to lesser extent, in the otosclerotic regions, the latter previously believed to be inactive. β2-laminin and ubiquitin were uniformly expressed in both otospongiotic and otosclerotic regions. There was a basal level of expression of all of these markers in the normal hearing and sensorineural hearing loss specimens utilized as control. TGF β -1, however, though present in the otosclerosis bones, was absent in the normal hearing and sensorineural hearing loss controls.

CONCLUSIONS

Our results propose that the activity and function of TGF-1 may play a key role in the development and pathogenesis of otosclerosis. Further studies utilizing a higher number of temporal bone specimens will be helpful for future analysis and to help decipher its role as a potential target in therapeutic interventions.

摘要

目的

通过免疫组织化学和免疫荧光技术研究各种分子标志物的作用和分布,进一步阐明和理解耳硬化症的发病机制。

方法

对 7 例经诊断为耳硬化症的患者的存档细胞素甲醛固定的 20 微米厚组织切片进行研究,并与对照组进行比较。在中鼓室区域的切片用针对腱糖蛋白-1、β2-层粘连蛋白、胶原-IX、BSP 的兔多克隆抗体以及针对 TGFβ-1 和泛素的单克隆抗体进行免疫反应。使用高分辨率的光和激光共聚焦显微镜获取数字图像。

结果

腱糖蛋白-1、BSP 和胶原-IX 在耳海绵状区域表达,在耳硬化区域表达较少,后者以前被认为是不活跃的。β2-层粘连蛋白和泛素在耳海绵状和耳硬化区域均均匀表达。在用作对照的正常听力和感音神经性听力损失标本中,所有这些标志物都有基础表达水平。然而,TGFβ-1 虽然存在于耳硬化骨中,但在正常听力和感音神经性听力损失对照中不存在。

结论

我们的结果表明,TGF-β1 的活性和功能可能在耳硬化症的发展和发病机制中起关键作用。进一步利用更多的颞骨标本进行研究将有助于未来的分析,并有助于阐明其作为治疗干预潜在靶点的作用。

相似文献

1
Dynamic Molecular Markers of Otosclerosis in the Human Cochlea.人类耳蜗耳硬化症的动态分子标志物。
Ann Otol Rhinol Laryngol. 2024 Apr;133(4):390-399. doi: 10.1177/00034894231225134. Epub 2024 Jan 10.
10
Analysis of the Hyalinization Reaction in Otosclerosis.耳硬化症中透明样变反应的分析
JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):555-9. doi: 10.1001/jamaoto.2014.427.

本文引用的文献

2
History of Otosclerosis and Stapes Surgery.耳硬化症及镫骨手术史
Otolaryngol Clin North Am. 2018 Apr;51(2):275-290. doi: 10.1016/j.otc.2017.11.003.
3
Immunohistochemical techniques for the human inner ear.人类内耳的免疫组织化学技术
Histochem Cell Biol. 2016 Oct;146(4):367-87. doi: 10.1007/s00418-016-1471-2. Epub 2016 Aug 1.
7
The genetics of otosclerosis.耳硬化症的遗传学。
Hear Res. 2010 Jul;266(1-2):70-4. doi: 10.1016/j.heares.2009.07.002. Epub 2009 Jul 14.
9
Detection of rare nonsynonymous variants in TGFB1 in otosclerosis patients.耳硬化症患者中TGFB1基因罕见非同义变异的检测
Ann Hum Genet. 2009 Mar;73(2):171-5. doi: 10.1111/j.1469-1809.2009.00505.x. Epub 2009 Jan 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验